Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Registry sponsor category
Industry
- Other names
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Company name
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (9)
- A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
- A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants
- A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
- Aleniglipron Phase 2 Body Composition Study
- Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus